Accueil / Tag Archives: Clinical Trials

Tag Archives: Clinical Trials

Lineage Cell Therapeutics to Present at Dawson James Securities 5th Annual Small Cap Growth Conference on October 29, 2019

Tuesday, October 22nd 2019 at 12:00pm UTC CARLSBAD, Calif.–(BUSINESS WIRE)– Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that Brandi L. Roberts, Chief Financial Officer, will be presenting at the Dawson James Securities 5th Annual …

Plus »

Quotient Sciences Appoints Claes Glassell as Non-Executive Chairman of Board of Directors

Tuesday, October 22nd 2019 at 1:00pm UTC NOTTINGHAM, England–(BUSINESS WIRE)– Quotient Sciences, the innovative drug development and manufacturing organization, today announces the appointment of Claes Glassell as non-executive chairman of its board of directors. A highly accomplished leader in the pharmaceutical industry with over 35 years’ experience, Glassell has held …

Plus »

Takeda obtient une licence pour le traitement de la maladie cœliaque de première classe de COUR Pharmaceuticals à la suite d’une étude de validation de principe positive de phase 2a

Tuesday, October 22nd 2019 at 6:15pm UTC ? Les données les plus récentes d’une étude de phase 2a présentée lors de la UEG Week 2019, à Barcelone, en Espagne, soulignent le potentiel de la médecine expérimentale pour prévenir l’activation immunitaire induite par le gluten chez les patients atteints de la …

Plus »

Tiaki Therapeutics Presents Data on Identification of a Novel Target for Neuroinflammatory-driven Neurodegenerative Disease Validated by Its Systems Biology Platform

Monday, October 21st 2019 at 4:00pm UTC Proprietary platform recapitulates neuroinflammatory signature from Alzheimer’s Disease patients Data presented at Society for Neuroscience 49th Annual Meeting CAMBRIDGE, Mass.–(BUSINESS WIRE)– Tiaki Therapeutics, a company developing treatments for patients suffering from age-related dementias by targeting the neuroinflammation that drives cognitive decline, announced today …

Plus »

AVROBIO Appoints Holly May as Chief Commercial Officer

Tuesday, October 22nd 2019 at 11:00am UTC Company developing commercial strategies and operational capabilities to support future product launches as investigational gene therapies advance through clinic Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4) CAMBRIDGE, Mass.–(BUSINESS WIRE)– AVROBIO, Inc. (NASDAQ: AVRO) (the “Company”), a Phase 2 clinical-stage gene …

Plus »

Takeda adquiere la licencia de la innovadora terapia para la enfermedad celíaca de COUR Pharmaceuticals después de un estudio positivo de fase 2a de prueba de concepto

Tuesday, October 22nd 2019 at 1:29pm UTC ? Datos de última hora de un estudio de fase 2a presentados en la UEG Week 2019, Barcelona, España, destacan el potencial de un fármaco en investigación para prevenir la activación inmunitaria inducida por el gluten en pacientes con enfermedad celíaca ? Takeda …

Plus »

Sonnet BioTherapeutics Selects Abzena as Clinical Stage Manufacturing Partner for its IL-12-FHAB cytokine-derived Therapeutic Candidate

Tuesday, October 22nd 2019 at 1:28pm UTC PRINCETON, N.J. & SAN DIEGO–(BUSINESS WIRE)– Sonnet BioTherapeutics Inc., a clinical stage biopharmaceutical developing innovative targeted biologic drugs, announced today that it has selected Abzena as its manufacturing partner for SON-1010, an IL-12-FHAB cytokine, in preparation for clinical development. SON-1010 uses Sonnet’s proprietary …

Plus »

Venarum Medical Receives Ongoing NIH SBIR Grant Support for its EndoVenous Valve System Development

Monday, October 21st 2019 at 7:44pm UTC Ongoing NIH SBIR Support Enables Progress Towards a Prosthetic Venous Valve EATONTOWN, N.J.–(BUSINESS WIRE)– Venarum Medical, LLC today announced receipt of a mentorship grant in further support of its awarded Phase II SBIR Grant “EVVS: EndoVenous Valve System” currently underway. Under its Phase …

Plus »

FARXIGA Approved in the US to Reduce the Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes

Monday, October 21st 2019 at 11:00am UTC WILMINGTON, Del.–(BUSINESS WIRE)– AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved FARXIGA (dapagliflozin) to reduce the risk of hospitalization for heart failure (hHF) in adults with type 2 diabetes (T2D) and established cardiovascular disease (CVD) or multiple cardiovascular …

Plus »

Mycovia Pharmaceuticals to Present at 2019 BIO Investor Forum

Monday, October 21st 2019 at 2:30pm UTC CEO Patrick Jordan to highlight the need for increased industry focus and investment in advancing women’s health Company selected to present as a “Buzz of BIO” Late Stage Leader DURHAM, N.C.–(BUSINESS WIRE)– Mycovia Pharmaceuticals, Inc. (“Mycovia”) today announced that Chief Executive Officer Patrick …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.